QT
CPRX

Quantamental Technologies’s Catalyst Pharmaceutical CPRX Stock Holding History

Quantamental Technologies’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,296
Closed -$72K – 530
2022
Q2 		$72K Buy
+10,296
New +$75.5K 0.03% 391

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quantamental Technologies's CPRX Position: Q3 2022 in Review

Quantamental Technologies sold out of Catalyst Pharmaceutical (CPRX) in Q3 2022, closing a stake of 10,296 shares — an estimated $72K sold.

Quantamental Technologies first reported a position in CPRX in Q2 2022 and held it in 1 quarter. The position peaked at $72K in Q2 2022. 229 funds tracked by Wall St. Rank hold CPRX as of Q3 2022.

  • Quantamental Technologies reported no remaining Catalyst Pharmaceutical position as of Q3 2022 after selling out during the quarter.
  • Quantamental Technologies sold 10,296 Catalyst Pharmaceutical shares in Q3 2022, an estimated $72K.
  • Quantamental Technologies first reported a position in Catalyst Pharmaceutical in Q2 2022 and held it in 1 quarter.
  • Quantamental Technologies's Catalyst Pharmaceutical position peaked at $72K in Q2 2022.
  • 229 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2022.

Based on Quantamental Technologies's 13F filing for Q3 2022, filed 14 Nov 2022.